Efficacy and safety of SBR759, a novel calcium-free, iron (III)-based phosphate binder, versus placebo in chronic kidney disease stage V Japanese patients on maintenance renal replacement therapy

By Fukagawa Masafumi   Kasuga Hirotake   Joseph Devanand   Sawata Hiroshi   Junge Guido   Moore Alan   Akiba Takashi  

Clinical and Experimental Nephrology, Vol. 18, Iss. 1, 2014-02 ,pp. : 135-143

Springer Publishing Company

Access to resources Recommend Favorite

Inappropriate use of nonsteroidal anti-inflammatory drugs and other drugs in chronic kidney disease patients without renal replacement therapy

By Bilge Ugur  

Renal Failure, Vol. 35, Iss. 6, 2013-07 ,pp. : 906-910

Informa Healthcare

Access to resources Recommend Favorite

Thyroid hormone replacement therapy for primary hypothyroidism leads to significant improvement of renal function in chronic kidney disease patients

By Hataya Yuji   Igarashi Shuta   Yamashita Takafumi   Komatsu Yasato  

Clinical and Experimental Nephrology, Vol. 17, Iss. 4, 2013-08 ,pp. : 525-531

Springer Publishing Company

Access to resources Recommend Favorite

Anemia and Cardiovascular Disease, Hospitalization, End Stage Renal Disease, and Death in Older Patients with Chronic Kidney Disease

By Li Shuling   Foley Robert   Collins Allan  

International Urology and Nephrology, Vol. 37, Iss. 2, 2005-06 ,pp. : 395-402

Springer Publishing Company

Access to resources Recommend Favorite

Clinical findings in oral health during progression of chronic kidney disease to end-stage renal disease in a Swedish population

By Thorman Royne   Neovius Martin   Hylander Britta  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 2, 2009-03 ,pp. : 154-159

Informa Healthcare

Access to resources Recommend Favorite